Parallel Advisors’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.31K Hold
309
– – ﹤0.01% 3506
2026
Q2
$3.39K Sell
309
-204
-40% -$1.92K ﹤0.01% 3361
2026
Q1
$4.17K Buy
513
+270
+111% +$2.32K ﹤0.01% 3102
2025
Q4
$2.52K Hold
243
– – ﹤0.01% 3071
2025
Q3
$2.15K Sell
243
-398
-62% -$2.84K ﹤0.01% 3028
2025
Q2
$3.7K Buy
+641
New +$3.93K ﹤0.01% 2849
2025
Q1
– Sell
-212
Closed -$1.65K – 3602
2024
Q4
$1.85K Buy
212
+40
+23% +$576 ﹤0.01% 2996
2024
Q3
$3.36K Hold
172
– – ﹤0.01% 2744
2024
Q2
$3.54K Buy
+172
New +$3.54K ﹤0.01% 2633
2022
Q3
– Sell
-11
Closed – – 3339
2022
Q2
$0 Buy
+11
New +$158 ﹤0.01% 3183
2021
Q3
– Sell
-11
Closed – – 3172
2021
Q2
$0 Sell
11
-40
-78% -$993 ﹤0.01% 2993
2021
Q1
$1K Hold
51
– – ﹤0.01% 2643
2020
Q4
$2K Sell
51
-86
-63% -$3.02K ﹤0.01% 2319
2020
Q3
$4K Hold
137
– – ﹤0.01% 2105
2020
Q2
$2K Buy
+137
New +$1.98K ﹤0.01% 2203

Other funds holding KURA

Parallel Advisors's KURA Position: Q3 2026 in Review

Parallel Advisors held its Kura Oncology (KURA) position steady in Q3 2026 at 309 shares worth $3.31K. The position accounts for ﹤0.01% of the portfolio, ranked #3506.

Parallel Advisors first reported a position in KURA in Q2 2020 and has held it in 15 quarters since. The position peaked at $4.17K in Q1 2026. 55 funds tracked by Wall St. Rank hold KURA as of Q3 2026.

  • Parallel Advisors held 309 shares of Kura Oncology worth $3.31K as of Q3 2026.
  • Parallel Advisors left its Kura Oncology share count unchanged in Q3 2026.
  • Kura Oncology made up ﹤0.01% of Parallel Advisors's portfolio in Q3 2026, its #3506 holding.
  • Parallel Advisors first reported a position in Kura Oncology in Q2 2020 and has held it in 15 quarters since.
  • Parallel Advisors's Kura Oncology position peaked at $4.17K in Q1 2026.
  • 55 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2026.

Based on Parallel Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.